PTEN, a tumor suppressor of the PI3K/Akt signaling pathway, is often downregulated by both genomic and non‐genomic mechanisms, leading to frequent loss of protein expression and function in human lung cancer [32]. This evidence concerns the gene AKT1 and lung cancer.